Trial Profile

Effect of Pitavastatin and EPA on coronary artery calcification detected by computed tomography.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 08 Sep 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pitavastatin (Primary) ; Eicosapentaenoic acid
Indications Atherosclerosis; Coronary artery disease; Dyslipidaemias
Focus Therapeutic Use
Acronyms PEACH

Most Recent Events

01 Sep 2017 Primary endpoint (CAC volume) has not been met as per the results published in the Circulation Journal
01 Sep 2017 Primary endpoint (The effect of Pitavastatin on coronary calcification score.) has not been met as per the results published in the Circulation Journal
01 Sep 2017 Results published in the Circulation Journal

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com